IGTAR faces going‑concern risk as SPAC extends AgileAlgo deal amid cash shortfall

Inception Growth Acquisition Limited (NASDAQ: IGTAR)

What's happening inside the company
Inception Growth is a blank‑check (SPAC) vehicle that has not commenced operating revenues and is focused on completing a business combination (the proposed deal is with AgileAlgo). Management continues to extend the SPAC life by depositing small extension fees into the Trust Account and relying on sponsor support. The company repeatedly extended outside closing dates (latest amendments moved the outside date into October 2025) but has a strained balance sheet and a working‑capital shortfall. Management warns there is substantial doubt about going concern if a business combination is not closed.

Income statement - positives
- The company still generates non‑operating income from the Trust Account (dividend/interest) that offsets some expenses: Dividend income for the three months ended June 30, 2025 was $33,301 and $71,249 for the six‑month period.
- Management is controlling operating spend to the extent possible for a SPAC post‑IPO (G&A is formation related and not ongoing operating revenue costs).
- No operating revenue expected until a business combination - users should treat current results as pre‑transaction cash management.

Income statement - negatives
- Significant swing versus prior year: Q2 2025 net (loss) of $(470,507) vs Q2 2024 net income $134,091 (dividend income materially lower in 2025).
- Dividend/interest income collapsed year‑over‑year: Q2 2025 $33,301 vs Q2 2024 $377,360 (six months 2025 $71,249 vs 2024 $798,010).
- Formation, general & administrative expense increased: Q2 2025 $503,808 vs Q2 2024 $203,825 - pressure on the bottom line until deal closes.
- Net loss allocated to non‑redeemable shares produces negative EPS: basic/diluted net loss per share, common stock not subject to possible redemption - Q2 2025 $(0.17); six months $(0.23).

Key points & statistics (facts as reported)
- Cash (outside Trust Account) at June 30, 2025: $59,063.
- Cash and investments held in Trust Account at June 30, 2025: $2,138,322.
- Total assets: $2,254,885 (June 30, 2025).
- Total liabilities: $6,874,473 (June 30, 2025).
- Working capital deficit: $4,507,910 (per liquidity discussion).
- Shareholders' deficit: $(6,757,910) at June 30, 2025.
- Common stock subject to possible redemption: 176,662 shares (redemption value noted at $12.10 per share; temporary equity balance $2,138,322).
- Accrued liabilities: $2,235,715; income tax payable: $194,267; note payable - related party: $1,540,000; amount due to related party: $654,491.
- Excise tax payable (related to buyback tax) included in accrued liabilities: $1,082,055 as of June 30, 2025 (note disclosures).
- Net loss: Three months ended June 30, 2025: $(470,507); Six months ended June 30, 2025: $(598,873).
- Dividend income: Q2 2025 $33,301; Q2 2024 $377,360. Six months 2025 $71,249; six months 2024 $798,010.
- Formation, general and administrative expense: Q2 2025 $503,808; six months 2025 $670,122.
- Cash flows - net cash used in operating activities (six months): $(395,510); net cash provided by investing activities (six months): $1,538,677; net change in cash: $54,768; cash at period end: $59,063.
- Sponsor support: advances/notes outstanding $1,540,000 (promissory notes) and amount due to related party $654,491 as of June 30, 2025.
- Extensions and deadlines: as of report the Company had extended repeatedly and had the right to extend to October 13 / September 13, 2025 (notes), and subsequent events include Amendment No.5 (July 31, 2025) extending the outside closing date to October 14, 2025; deposits into the Trust Account of $13,250 were made on July 7 and August 11, 2025 to extend available time to complete a business combination until September 13, 2025 (per subsequent events disclosure).

Bottom line / watchlist (straightforward)
- This is a SPAC with no operating revenue - results are dominated by Trust Account income and one‑time SPAC costs.
- Positive: Trust Account still holds ~$2.14M and the sponsor has provided funding/notes; dividend income continues (though much lower than prior year).
- Negative: liabilities exceed assets, large accumulated deficit, working capital shortfall and substantial doubt about continuing as a going concern if a business combination is not closed by the extended deadlines.
- Near‑term catalysts and risks: monitor Trust balance, extension payments, sponsor willingness to fund further extensions or convert loans, and progress/consummation of the AgileAlgo business combination before the October 2025 outside date.

Actionable takeaway: If you follow Inception Growth Acquisition Limited (NASDAQ: IGTAR), focus on the Trust Account trajectory, sponsor financing actions, and any firm closing date for the AgileAlgo transaction - those items will determine whether the SPAC converts to an operating company or liquidates (public shares could be redeemed or become worthless on liquidation).